Katalog der Deutschen Nationalbibliothek

Springe direkt zu:

Katalog (Beta)

Wissensnetz

Person
Person

Person

Nils Nicolay

Arzt

Name

Nils Nicolay

Zeit

2008- (Wirkungsdaten)

Ort

Deutschland

Geschlecht

männlich

Akademischer Grad bzw. Titel

Prof. Dr. Dr.

Beruf

Arzt (charakteristischer Beruf)

Variante

Nils Henrik Nicolay
Nils H. Nicolay
N. H. Nicolay

Beziehung

Radiologische Klinik (Heidelberg) (02/2014-07/2018)
Universität Heidelberg. Medizinische Fakultät (04/2017-10/2019)
Universitätsklinikum Freiburg. Klinik für Strahlenheilkunde

Weitere Angaben

Heidelberger Institut für Radioonkologie (HIRO); National Center for Radiation Research in Oncology (NCRO); Diss. Medizinische Fakultät der Univ. Heidelberg

Quelle

AM

Datensatztyp

Person

GND-Nummer

136200834

Datensatz-ID

136200834

Beteiligt an

alle anzeigen

Effects of tumor treating fields (TTFields) on human mesenchymal stromal cells

The role of the soft palate dose regarding normal tissue toxicities in older adults with head and neck cancer undergoing definitive radiotherapy

Multicenter analysis on the value of standard (chemo)radiotherapy in elderly patients with locally advanced adenocarcinoma of the esophagus or gastroesophageal junction

A multicenter evaluation of different chemotherapy regimens in older adults with head and neck squamous cell carcinoma undergoing definitive chemoradiation

Bedeutung der Tumor-Stroma-Eigenschaften für die Biologie von primären Plattenepithelkarzinomen der Lunge

Effects of tumor treating fields (TTFields) on human mesenchymal stromal cells

Implementation of PET/CT in radiation oncology - a patterns-of-care analysis of the German Society of Nuclear Medicine and the German Society of Radiation Oncology

Multicenter analysis on the value of standard (chemo)radiotherapy in elderly patients with locally advanced adenocarcinoma of the esophagus or gastroesophageal junction

Neuroprotection in radiotherapy of brain metastases: A pattern-of-care analysis in Germany, Austria and Switzerland by the German Society for radiation Oncology − working group Neuro-Radio-Oncology (DEGRO AG-NRO)

Oncologic treatment support via a dedicated mobile app: a prospective feasibility evaluation (OPTIMISE-1)

Patient-relevant costs for organ preservation versus radical resection in locally advanced rectal cancer

Radio(chemo)therapie für Kopf-Hals-Plattenepithelkarzinome: welchen Stellenwert hat die Standardtherapie bei älteren Patient*innen?

Satisfaction with radiotherapy care among cancer patients treated in Germany — secondary analysis of a large multicenter study

The role of ALBI score in patients treated with stereotactic body radiotherapy for locally advanced primary liver tumors: a pooled analysis of two prospective studies

The role of the soft palate dose regarding normal tissue toxicities in older adults with head and neck cancer undergoing definitive radiotherapy

The significance of partial volume effect on the estimation of hypoxic tumour volume with [18F]FMISO PET/CT

Satisfaction with radiotherapy care among cancer patients treated in Germany—secondary analysis of a large multicenter study

Oncologic treatment support via a dedicated mobile app: a prospective feasibility evaluation (OPTIMISE-1)

Psychosocial distress in cancer patients undergoing radiotherapy: a prospective national cohort of 1042 patients in Germany

Systemic immune modulation by stereotactic radiotherapy in early-stage lung cancer

Mobile applications in radiation oncology—current choices and future potentials

The influence of antibiotic administration on the outcomes of head-and-neck squamous cell carcinoma patients undergoing definitive (chemo)radiation

App-controlled treatment monitoring and support for patients with head and neck cancer undergoing radiotherapy: results from a prospective randomized controlled trial

Authors’ response to the letter to the editor by Busra Yilmaz and Ugur Selek regarding our study “The influence of antibiotic administration on the outcomes of head-and-neck squamous cell carcinoma patients undergoing definitive (chemo)radiation”

Authors’ response to the Letter to the Editor by Efsun Somay and Erkan Topkan regarding our study “The influence of antibiotic administration on the outcomes of head-and-neck squamous cell carcinoma patients undergoing definitive (chemo)radiation”

Chemoradiotherapy in geriatric patients with squamous cell carcinoma of the esophagus: multi-center analysis on the value of standard treatment in the elderly

Deep inspiration breath-hold radiation therapy in left-sided breast cancer patients: a single-institution retrospective dosimetric analysis of organs at risk doses

Evaluation of concomitant systemic treatment in older adults with head and neck squamous cell carcinoma undergoing definitive radiotherapy

Financial toxicity in cancer patients undergoing radiotherapy in a universal health care system – a prospective multicenter study of 1075 patients

Psychosocial distress in cancer patients undergoing radiotherapy: a prospective national cohort of 1042 patients in Germany

Systemic immune modulation by stereotactic radiotherapy in early-stage lung cancer

The influence of antibiotic administration on the outcomes of head-and-neck squamous cell carcinoma patients undergoing definitive (chemo)radiation

Prognostic value of tumor-infiltrating immune cells and immune checkpoints in elderly head-and-neck squamous cell carcinoma patients undergoing definitive (chemo)radiotherapy

Deep inspiration breath-hold radiation therapy in left-sided breast cancer patients: a single-institution retrospective dosimetric analysis of organs at risk doses

Palliative radiotherapy of bone metastases in octogenarians: How do the oldest olds respond? Results from a tertiary cancer center with 288 treated patients

ORATOR2-Studie – randomisierter Vergleich einer primären Operation oder primären Strahlentherapie bei HPV-positivem Oropharynxkarzinom im Kontext einer Therapiedeeskalation

Cost effectiveness and health-related quality of life of chemoradiotherapy versus radiation therapy alone in elderly head and neck cancer patients

Wöchentliche versus dreiwöchentliche Cisplatingabe bei der postoperativen Radiochemotherapie von lokal fortgeschrittenen Kopf-Hals-Plattenepithelkarzinomen – Ergebnisse der JCOG1008-Studie

Feasibility, pitfalls and results of a structured concept-development phase for a randomized controlled phase III trial on radiotherapy in primary prostate cancer patients

Bestrahlungsplan-Analysen bei Patientinnen mit bilateralen Mammakarzinomen : inzidentelle Dosisbelastungen und Toxizitäten im Vergleich verschiedener Bestrahlungsverfahren

Cost effectiveness and health-related quality of life of chemoradiotherapy versus radiation therapy alone in elderly head and neck cancer patients

Deeskalation der adjuvanten Radiotherapie nach transoraler Resektion HPV-positiver Oropharynxkarzinome: Ergebnisse der E3311-Studie = De-escalation of adjuvant radiotherapy after transoral surgery of HPV-associated oropharyngeal cancer: results of the E3311 trial

Feasibility, pitfalls and results of a structured concept-development phase for a randomized controlled phase III trial on radiotherapy in primary prostate cancer patients

Financial toxicity in cancer patients treated with radiotherapy in Germany - a cross-sectional study

Human mesenchymal stromal cells do not cause radioprotection of head-and-neck squamous cell carcinoma

Incidental irradiation of the regional lymph nodes during deep inspiration breath-hold radiation therapy in left-sided breast cancer patients: a dosimetric analysis

Interleukin-6 as surrogate marker for imaging-based hypoxia dynamics in patients with head-and-neck cancers undergoing definitive chemoradiation - results from a prospective pilot trial

Intraindividual comparison between [18F] PSMA-1007 PET/CT and multiparametric MRI for radiotherapy planning in primary prostate cancer patients

ORATOR2-Studie – randomisierter Vergleich einer primären Operation oder primären Strahlentherapie bei HPV-positivem Oropharynxkarzinom im Kontext einer Therapiedeeskalation = ORATOR2 trial: randomized comparison of primary surgery vs. primary radiotherapy for HPV-associated oropharyngeal cancer in the context of de-escalated therapy

Palliative radiotherapy of bone metastases in octogenarians: How do the oldest olds respond? Results from a tertiary cancer center with 288 treated patients

Patterns-of-Care analysis for radiotherapy of elderly head-and-neck cancer patients: a trinational survey in Germany, Austria and Switzerland

Prognostic value of tumor-infiltrating immune cells and immune checkpoints in elderly head-and-neck squamous cell carcinoma patients undergoing definitive (chemo)radiotherapy

Risk factors for biochemical recurrence after PSMA-PET-guided definitive radiotherapy in patients with de novo lymph node-positive prostate cancer

Sarcopenia as a prognostic marker in elderly head and neck squamous cell carcinoma patients undergoing (chemo-)radiation

The value of plasma hypoxia markers for predicting imaging-based hypoxia in patients with head-and-neck cancers undergoing definitive chemoradiation

Wöchentliche versus dreiwöchentliche Cisplatingabe bei der postoperativen Radiochemotherapie von lokal fortgeschrittenen Kopf-Hals-Plattenepithelkarzinomen – Ergebnisse der JCOG1008-Studie = Weekly versus three-weekly cisplatin for the postoperative chemoradiation of locally advanced head-and-neck squamous cell carcinoma: results of the JCOG1008 trial

Interleukin-6 as surrogate marker for imaging-based hypoxia dynamics in patients with head-and-neck cancers undergoing definitive chemoradiation—results from a prospective pilot trial

Innovative radiation oncology Together – Precise, Personalized, Human : Vision 2030 for radiotherapy & radiation oncology in Germany

The value of primary and adjuvant radiotherapy for cutaneous squamous cell carcinomas of the head-and-neck region in the elderly

Biologically consistent dose accumulation using daily patient imaging
Hinweis

Die Betaversion beinhaltet noch nicht alle Funktionen und Informationen des Katalogs des DNB-Portals. Falls Sie Informationen vermissen oder ein Medium bestellen wollen, besuchen Sie bitte die entsprechende Seite im Katalog des DNB-Portals über folgenden Link:

DNB-Portal